Business Wire

ROKA Launches Ultralight Advanced Performance Eyewear with World-Class Roster of Athletes

Del

ROKA Sports Inc., the Austin, TX based performance multisport company, has announced the release of its new Advanced Performance for Extreme Conditions (A.P.EX) line of eyewear. The collection was designed from scratch for the athlete who requires maximum field of view, protection, ultra-lightweight, and seamless fit and retention. The Advanced Performance collection is incredibly versatile, coming in five styles and up to ten lens tint options, so athletes can completely customize their eyewear to meet their specific needs.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180313006426/en/

(Photo: Business Wire)

(Photo: Business Wire)

The unique design of ROKA’s Advanced Performance collection is the realization of more than two years of stealth R&D by ROKA’s eyewear division, an all-star team of designers and engineers based in Irvine, California, who were assembled specifically for this mission and were drawn from Apple, Oakley, Under Armour, and other leading brands. Upon formation, ROKA Co-Founders Rob Canales and Kurt Spenser challenged the team, which has over 110 years combined experience making performance eyewear, to design and build the best sport optics on the planet from the inside out, with a primary focus on function in extreme conditions.

“This is truly a breakthrough in performance eyewear,” says ROKA Co-Founder and CEO Rob Canales. “We build products for the most demanding athletes in the world, and through meticulous attention to detail and the aggregation of incremental gains, our team has delivered. While other brands are cutting performance and quality to satisfy their monopolist owners, we’ve gone all in with a truly independent line that is with uncompromising performance.”

The A.P.EX line consists of three different frame options, with multiple lens height configurations: The SL-1, SL-1x, SR-1, SR-1x, and TL-1. Weighing in at only 21 – 25 grams, every style features ultra-lightweight materials and construction without compromising durability. An adjustable titanium core offers a customized fit, and advanced materialization with ROKA’s patented GEKO™ technology on the nose pads and temples ensure a rock solid fit under the most adverse training and racing conditions.

All five styles feature premium nylon lens options by Carl Zeiss Vision that come standard with market-leading hydrophobic, oleophobic, anti-scratch, anti-fog, and anti-reflectance coatings. Whether riding in the glaring sun or running through rain and snow, athletes will have multiple contrast and mirror options for the specific demands of the day.

“The moment I slipped on the ROKA sunglasses, I knew they had set a new standard in the performance eyewear market,” says eight-time triathlon world champion Javier Gómez. “There is nothing else that comes close in terms of weight, security, and optics. ROKA’s technical apparel and goggles have been a secret weapon for me in multiple world championships. I’m thrilled to have that same world-beating standard for my eyewear.”

Gómez is one of more than 40 elite athletes to debut the Advanced Performance eyewear in 2018. Regardless of the arena or challenge, ROKA eyewear is designed for athletes seeking to redefine standards, to break barriers, and to find every advantage possible. Within a few weeks of their release, Carlos Sainz drove them to victory at the Dakar Rally in South America, and Esmee Visser took them to the top of the Olympic podium in speed skating in PyeongChang.

“I first tried ROKA sunglasses in January—about a month before the Olympics,” Visser says. “The sunglasses I used previously were good, but I always had problems with my eyes tearing up. With ROKA’s SR-1 sunglasses, I had better protection and fewer tears, and they weighed less, so it was an easy decision to use them at the Olympics.”

Advanced Performance optics have also helped pro cyclists Bryan Coquard and Magnus Cort Nielsen reach the top of the World Tour podium in 2018, out-sprinting the best cyclists in the world. They will also be the eyewear of choice for Dan Martin this July when he attempts to become the second Irishman ever to win the Tour de France.

“I pride myself on being innovative and finding every little advantage that I can,” says Martin. “When I looked into the ROKA brand, I knew they fit with my philosophy.” Martin says. “From the moment I put on the Advanced Performance eyewear, I knew ROKA had designed something truly better. The weight and fit is unlike anything else I’ve ever tried.”

Remaining true to its DNA as the top endurance sports brand in the world and its roots as the leading high-performance triathlon brand, a large number of triathletes including Ironman Linsey Corbin, the fastest American woman at the Iron distance, have chosen ROKA as their eyewear partner for the hardest single-day endurance event in the world, joining Gómez and original ROKA athlete Jesse Thomas.

The mission to create the most advanced high-performance eyewear on the planet began with the challenge presented by ROKA’s first sponsored athlete, Jesse Thomas, who wanted to blend his classic style of retro aviators with the lightweight fit and protection of high-performance optics.

“We’re passionate about designing the most advanced high performance products on the market for athletes who seek to redefine the standard. We are a dedicated team of creators, designers, engineers, and athletes who share that mission. We are incredibly proud of the results thus far. Stay tuned.” says ROKA Co-Founder and Chief Creative Officer, Kurt Spenser. “This incredible group of athletes all share a commitment to perform at the highest level in their respective arenas, and to go beyond what was previously thought possible. We work tirelessly to honor that commitment by delivering the most advanced eyewear in the world.”

Each of the five styles in the Advanced Performance collection has been optimized for specific use cases to accommodate a range of fit and function preferences. With its rimless design, the SL-1 and SL-1x provide athletes a completely unobstructed field of view and venting, even while in the extreme forward aero position under the hottest conditions. The SR-1 and SR-1x are designed for security, confidence, and speed for the absolutely fastest training and racing days, and they’re equally as comfortable underneath a helmet as they are out on the run. The sleek and stylish TL-1 is a high-performing, twin-lens sport frame that offers versatility, security, and ultralight performance, and is sure to be an instant favorite across a variety of applications.

All five styles feature ROKA’s patented GEKO™ pads on the nose and temples for optimal traction and comfort, as well as titanium core wires in the temples to provide a customized fit for every athlete. The SL-1, SL-1x, SR-1 and SR-1x feature nine interchangeable accessory lens options, so athletes can quickly change the tint to take on the specific conditions of any ride, run or race. The polarized lens options in the TL-1 are cut for superior optics and exceed all industry standards for polarization efficiency. ROKA’s proprietary polarization process minimizes distortion and warpage better than any other eyewear on the market.

“When we debuted our first line of eyewear in 2016, we sought to be the first brand to blend classic optical style with high performance and comfort,” said James Oman, Vice President of Engineering. “With the Advanced Performance line, we are pushing beyond limits to create a new standard of optics, protection and versatility. It’s a bold new category of eyewear that will forever change what athletes expect from a pair of sunglasses.”

About ROKA

ROKA started in a garage in Austin, Texas with humble beginnings and laser-beam focus. Our mission is to unlock human potential. To equip, empower, inspire and ignite. We serve those who seek to redefine the standard, to push themselves to the limit – whatever and wherever that may be. When we see an opportunity to innovate, to challenge the status quo, to disrupt a complacent or monopolistic market, we go all in.

Since our launch in 2013, our athletes have won over a dozen world titles and have been instrumental in the design and development of our patented and award-winning products. In 2016, we were proud to send 18 athletes to the Rio Olympics, and even prouder to take home Gold and Bronze. This year in PyeongChang, we continued the tradition, with ROKA athletes taking home Olympic Gold and Bronze in our most cutting edge products.

With our debut eyewear collection in late 2016, we have set a new bar by making ultralight performance eyewear with zero compromise on style, and with a patented design for sunglasses that stay put on your face even during the most extreme training and racing. Featuring a suite of the world's most advanced materials and patented technologies, our award-winning Ultralight Performance Eyewear delivers on our promise to create the finest technical equipment on the planet, full stop. For more information, visit www.roka.com/pages/contact-us.

Contact information

ROKA
Diane Thibert
VP Communications & Public Relations
(310) 804-2400
diane@roka.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 10:49Pressemelding

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41Pressemelding

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42Pressemelding

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00Pressemelding

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07Pressemelding

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha